09186372 is referenced by 8 patents and cites 1568 patents.

The present disclosure provides, inter alia, formulation compositions comprising modified nucleic acid molecules which may encode a protein, a protein precursor, or a partially or fully processed form of the protein or a protein precursor. The formulation composition may further include a modified nucleic acid molecule and a delivery agent. The present invention further provides nucleic acids useful for encoding polypeptides capable of modulating a cell's function and/or activity.

Title
Split dose administration
Application Number
13/898588
Publication Number
9186372 (B2)
Application Date
May 21, 2013
Publication Date
November 17, 2015
Inventor
Sayda M Elbashir
Cambridge
MA, US
Antonin de Fougerolles
Waterloo
BE
Agent
Jennifer F Bryan
Donna T Ward
DT WARD PC
Assignee
MODERNA THERAPEUTICS
MA, US
IPC
C12N 15/88
C12N 15/117
C12P 21/00
A61K 31/7088
C07K 2/00
A61K 9/00
C12N 15/00
A61K 38/48
A61K 9/127
A61K 31/7105
A61K 9/16
A61K 9/14
A61K 48/00
View Original Source